Physician · Surgeon · Scientist
Dr. Barbara Johnson
The Clinical Mind Behind the Cellular Intelligence Protocol™
30+
Years Clinical Practice
3
Disciplines Integrated
2
Virginia Clinic Locations
Philosophy
Why I Built the Cellular Intelligence Protocol™
I did not set out to build a protocol. I set out to answer a question my own medical training could not answer: how does a forty-five-year-old woman with no risk factors, no family history, no medications, and a body trained to elite athletic standards develop multiple sclerosis?
Conventional medicine had a treatment for the disease. It did not have an explanation for the patient.
What I found, after two decades of advanced training in cellular biology, functional medicine, and psychoneuroimmunology, was that the question itself had been wrong. MS was not the disease. MS was the symptom of a deeper biological event — the cell danger response locked in the "on" position, mitochondrial output collapsing, membrane integrity failing, and the nervous-endocrine-immune feedback loop misreading its own signals. The autoimmune diagnosis was the smoke. The fire was cellular.
That insight is the foundation of the Cellular Intelligence Protocol™. It is not a wellness program. It is a sequenced clinical framework built on three pillars — cell danger response, bioenergetic core, and psychoneuroimmunology — applied in the order cellular biology actually requires.
How I Think About Medicine
- Population averages do not treat individuals.
- Sequence is not optional.
- Psychoneuroimmunology is not an add-on — Pert demonstrated this at the molecular level, and Picard has extended it into the mitochondria.
- Mechanism beats management.
- Optimization without diagnostics is biohacking.
MS was not the disease. MS was the symptom of a deeper biological event — the cell danger response locked in the "on" position. The autoimmune diagnosis was the smoke. The fire was cellular.
Training
The Training That Built It
The CIP™ is not the product of a single fellowship or a weekend certification. It is the synthesis of multiple bodies of work I spent twenty years studying, often with the people who originated them.
Cellular and Bioenergetic Medicine
A fellowship in cellular medicine, certification in peptide therapy, and direct application of the cell danger response framework first articulated by Dr. Robert Naviaux at UC San Diego. CDR is the central organizing principle of how I think about chronic illness — it is what tells me whether a patient's biology is in defense or in repair, and it is the first thing I address. You cannot rebuild bioenergetic capacity in a system that still believes it is under threat.
Underneath this work sits Dr. Martin Picard's research at Columbia on mitochondrial psychobiology. Picard's work demonstrates what clinicians who pay attention have suspected for years: mitochondria are not just energy producers. They are signaling organelles that respond to psychological state, social environment, and behavior. His peer-reviewed work on mitochondria as 'social organelles' is the scientific bridge between the cellular pillar of my protocol and the psychoneuroimmunology pillar. The two are not separate disciplines. They are different observations of the same biology.
Functional Systems Medicine
Comprehensive training through the Institute for Functional Medicine in cardiometabolic, immunology, detoxification, GI, and hormone modules. IFM taught me to see the body as interconnected systems rather than organ silos — but it also showed me where functional medicine itself plateaus. The CIP™ was built to move past those limitations by sequencing the work cellularly rather than systemically.
Cognitive and Neurodegenerative Medicine
Direct training with Dr. Dale Bredesen in the Cognoscopy and Bredesen Protocol for Alzheimer's prevention and treatment. Bredesen's work proved what most neurology denies: cognitive decline is a multifactorial cellular event that can be reversed when caught early enough and addressed at the mechanism. That same principle — find the inputs, restore the cell — applies far beyond cognition.
Lipid and Plasmalogen Biochemistry
Advanced training in Dr. Dayan Goodenowe's plasmalogen framework, which identifies the membrane lipid deficit underlying neurodegenerative, autoimmune, and accelerated-aging conditions. Plasmalogen status is one of the most important markers most physicians have never measured — and one of the most actionable.
Mind-Body Medicine and Psychoneuroimmunology
Certification through Harvard Medical School's Mind-Body Medicine program, founded by Dr. Herbert Benson — the cardiologist who first demonstrated the relaxation response and built the institutional foundation for mind-body medicine in the academic setting. The certification is one credential among many. The deeper work is twenty years of study in the field Dr. Candace Pert founded.
Pert's discovery of the opiate receptor and her subsequent work on neuropeptides established something most of medicine still has not fully integrated: emotions are not abstract psychological events. They are chemical signaling cascades, mediated by neuropeptides that bind to receptors on every cell in the body — including immune cells. The nervous system, endocrine system, and immune system are not three separate systems. They are one network. Pert called it the 'psychosomatic network.' That framework — receptor-level, molecular, mechanistic — is the foundation of how I think about stress, emotion, and chronic illness clinically.
Endocrinology, Genomics, and Regenerative Medicine
Certification in Advanced Endocrinology through A4M, certification in Anti-Aging and Regenerative Medicine, specialist credentials in Hormone Replacement Therapy, and certification in Clinical Genomic Analysis with extensive training in epigenetics and metabolomics. The four-system endocrine assessment I use — sex hormones, thyroid, adrenal/HPA, and growth hormone/IGF-1 — is built on this training. Genomic data layers underneath it to tell us how a specific patient is wired to respond.
Foundation
Board certification in General Surgery, Trauma, and Intensive Care. Twenty years operating on the consequences of unaddressed cellular dysfunction. That experience is not decorative. It is the reason I know what serious pathology looks like and when to rule it out before optimization begins.
Clinical Edge
What I Look For That Most Physicians Don't
These are the assessments and interventions that define how I work and that most patients have never been offered.
Mitochondrial Function as a Measured Variable
PNOE VO₂max analysis to assess cellular energy production in real time. Mitochondrial peptides — SS-31 and MOTS-c — as targeted interventions when bioenergetic capacity is the limiting variable.
Plasmalogen Status
Membrane lipid integrity assessed using Goodenowe's framework. Plasmalogen depletion is one of the most consistent findings I see in complex neuropathy, accelerated aging, and treatment-resistant autoimmune presentations.
Cell Danger Response as a Clinical Category
I read CDR markers and patterns the way a cardiologist reads an EKG — as a real-time report on whether the cell is in defense, transition, or repair. The treatment plan changes accordingly.
Four-System Endocrine Assessment
Sex hormones, thyroid, adrenal/HPA, and growth hormone/IGF-1 — assessed together because they fail together. Single-axis hormone replacement produces partial results in patients whose other three axes are compensating.
Receptor-Level Hormone Management
I treat to receptor function, not lab values. Two patients with identical estradiol levels can have completely different clinical pictures depending on receptor density and membrane fluidity.
Genomic Context with IntellxxDNA
Genetic data is not a horoscope. It tells me which interventions are likely to work, which are likely to fail, and where the patient's biology has narrow tolerances I need to respect.
Peptide Therapy at the Mechanistic Level
Not the trend list. Peptides selected to address the specific upstream defect — mitochondrial, immune, regenerative, neurologic — that the diagnostics identified.
Standard
The Standard I Hold Myself To
Every treatment protocol at The Johnson Center is personally researched and reviewed by me. I do not delegate clinical thinking to templates. I read the literature in cellular medicine, peptide research, and longevity science weekly — not because it is a content strategy, but because the field is moving fast enough that anyone not reading is falling behind.
I am sixty-seven. I have run the protocol on myself for over two decades. My MS is in sustained remission — not managed, remitted. I am healthier, sharper, and more biologically resilient now than I was at forty. That is not a marketing statement. It is the longest-running case study of the CIP™ that exists, and the patient is me.
"I am healthier, sharper, and more biologically resilient now than I was at forty."
20+ Years on the Protocol
Beyond the Clinic
What Comes Next
The work I am doing in Virginia is the foundation of something larger. I am writing the clinical and patient-facing material that will train the next generation of physicians who want to practice this kind of medicine — and the patients who refuse to accept that decline at midlife is normal.
A residential program for the deeper work — what happens when a depleted nervous system, a misaligned life, and a cellular system that no longer remembers what repair feels like all need to be addressed together — is in development.
Most of what I have built at The Johnson Center is the medical layer of a larger answer to a question I think every high-functioning person eventually asks: what does it take to actually live the life I am still here to live?
That question is the reason I am still in clinical practice.